This article in ISMPPs May newsletter got me thinking about the way we evaluate literature. If we agree that there is a need to redefine...
Theranica received FDA approval for its smartphone-controlled electroceutical for the acute treatment of migraine.
This is yet another...
This World MS Day, I am joining several thousand delegates at the 2019 CMSC (Consortium of Multiple Sclerosis Centres) conference in...
According to experts, it seems imminent that news channels will be reporting on the first U.S. infant death from measles in almost 40...
Hire cognitive diversity whilst providing psychological safety. This may not have been David Rowan’s intended primary message at his...
Four years after its initial EU market authorisation, NICE recommended Celgene’s Revlimid® as a first-line treatment in...
I've been bilaterally profoundly deaf since I was 18 months old (an unfortunate side effect of a severe bacterial meningitis infection I...
Digital strategy in healthcare as part of the wider digital health environment is coming more and more into focus at the large...
Kenan Malik wrote an opinion piece in the Guardian this week (Sunday 5th May) that summarized a key problem facing R&D in pharma;...
For all the successes that the checkpoint inhibitors (CPIs) have had over the past 8 years since their first approvals, and all the...
The burgeoning field of cell and gene therapies collectively referred to as Advanced Therapeutics (ADVTX), is at last beginning to...
I have just attended a panel discussion at Bio Trinity 2019 and thought it was worth summarising the challenges the panellists described...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
